Griffin Securities Starts AmpliPhi Biosciences (APHB) at Buy
Tweet Send to a Friend
Griffin Securities initiates coverage on AmpliPhi Biosciences (NYSE: APHB) with a Buy rating and a price target of $10.00.Analyst Keith ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
